BofA raises Sanmina stock to neutral, price target to $92

Published 29/01/2025, 10:58 pm
BofA raises Sanmina stock to neutral, price target to $92

The analysts concluded that their Neutral rating balances the positive aspects against the potential negatives, indicating a more cautious yet optimistic stance on Sanmina's stock. Based on InvestingPro's comprehensive analysis, which includes over 30 key metrics and financial health indicators, Sanmina currently shows a "GOOD" overall financial health score. Subscribers can access the full Pro Research Report for detailed insights into Sanmina's valuation, growth prospects, and industry positioning. Based on InvestingPro's comprehensive analysis, which includes over 30 key metrics and financial health indicators, Sanmina currently shows a "GOOD" overall financial health score. Subscribers can access the full Pro Research Report for detailed insights into Sanmina's valuation, growth prospects, and industry positioning. The upgrade reflects a more favorable outlook for the company, as the communications end market, which accounts for 20% of the company's revenue in fiscal 2024, is expected to recover from an inventory correction and see revenue growth in fiscal 2025.

The analysts concluded that their Neutral rating balances the positive aspects against the potential negatives, indicating a more cautious yet optimistic stance on Sanmina's stock. Based on InvestingPro's comprehensive analysis, which includes over 30 key metrics and financial health indicators, Sanmina currently shows a "GOOD" overall financial health score. Subscribers can access the full Pro Research Report for detailed insights into Sanmina's valuation, growth prospects, and industry positioning.

The company's cloud infrastructure revenue, which represented 15% of revenue in fiscal 2024, is also expected to grow as demand increases, particularly with the expansion at hyperscale. The Industrial, Medical (TASE:PMCN), Defense, and Automotive (IMDA) segment saw modest growth of 1% year-over-year in the first quarter of fiscal 2025, but management is optimistic about growth across most end markets for the full fiscal year, with the medical sector remaining stable.

However, BofA Securities also cautioned about the challenging operating environment Sanmina faces. The company's guidance is contingent upon program ramps materializing in the second half of the fiscal year to drive revenues and operational leverage. There is also a risk that weak end markets could lead to program pushouts.

The analysts concluded that their Neutral rating balances the positive aspects against the potential negatives, indicating a more cautious yet optimistic stance on Sanmina's stock.

In other recent news, Sanmina Corporation reported strong fourth-quarter earnings, with revenue reaching $2.02 billion, surpassing the anticipated range of $1.9 billion to $2.0 billion. The company's non-GAAP earnings per share (EPS) of $1.43 also exceeded forecasts. Further, Sanmina closed the fiscal year with a robust $626 million in cash and cash equivalents, and no outstanding debt.

The company has appointed a new Global Controller and Chief Accounting Officer, demonstrating its commitment to maintaining a strong leadership structure. Sanmina is also investing in AI to enhance manufacturing efficiency and supply chain operations.

In terms of future expectations, Sanmina anticipates high-single-digit revenue growth in fiscal 2025, driven by diversified markets and new programs. The company is also focusing on margin expansion, aiming for operating margins of 5% to 6% in the short term.

Lastly, Sanmina's partnership with Reliance Industries (NSE:RELI) in India continues to progress well, with the joint venture aiming to capitalize on growth opportunities in India as it becomes a major exporter of high-tech products. These are among the recent developments at Sanmina.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.